2nd Annual AAV Gene Therapy Symposium in the Texas Medical Center (TMC).

Gene therapy as a field is finally coming of age, with clinically approved products in Europe and now in the US. One of the most promising vector technologies investigated for gene therapy currently is the Adeno-Associated Virus (AAV).

This symposium aims to bring together investigators in the TMC who develop or use AAV vectors for a variety of basic science or therapeutic purposes. We hope to facilitate and encourage inter-institutional collaboration between AAV developers, users, core facilities, and industry as well as to serve as a great opportunity for other researchers to learn about AAV vectors and their applications.